Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1945 1
1946 3
1947 5
1948 3
1949 2
1955 1
1964 1
1969 2
1971 1
1972 1
1973 1
1974 4
1975 10
1976 11
1977 13
1978 15
1979 9
1980 11
1981 18
1982 26
1983 22
1984 25
1985 30
1986 22
1987 43
1988 59
1989 54
1990 68
1991 63
1992 74
1993 79
1994 100
1995 109
1996 126
1997 130
1998 146
1999 144
2000 168
2001 192
2002 225
2003 240
2004 285
2005 329
2006 312
2007 339
2008 397
2009 403
2010 434
2011 524
2012 557
2013 567
2014 648
2015 649
2016 646
2017 625
2018 653
2019 724
2020 751
2021 707
2022 615
2023 552
2024 137

Text availability

Article attribute

Article type

Publication date

Search Results

11,707 results

Results by year

Filters applied: . Clear all
Page 1
Clinical Updates for Colon Cancer Care in 2022.
Fabregas JC, Ramnaraign B, George TJ. Fabregas JC, et al. Clin Colorectal Cancer. 2022 Sep;21(3):198-203. doi: 10.1016/j.clcc.2022.05.006. Epub 2022 Jun 3. Clin Colorectal Cancer. 2022. PMID: 35729033 Review.
Colon cancer needs better screening and treatment options. Its incidence in the young population is rising. ...This review presents the recently published evidence regarding screening and treating patients with colon cancer....
Colon cancer needs better screening and treatment options. Its incidence in the young population is rising. ...This review pre
Pathophysiology, clinical presentation, and management of colon cancer.
Cappell MS. Cappell MS. Gastroenterol Clin North Am. 2008 Mar;37(1):1-24, v. doi: 10.1016/j.gtc.2007.12.002. Gastroenterol Clin North Am. 2008. PMID: 18313537 Review.
Conventional adenomas arise from mutation of the APC gene; progression to colon cancer is a multistep process. The fundamental genetic defect in serrated adenomas is unknown. Environmental factors can increase the risk for colon cancer. Advanced col
Conventional adenomas arise from mutation of the APC gene; progression to colon cancer is a multistep process. The fundamental …
Predictive biomarkers of colon cancer immunotherapy: Present and future.
Hou W, Yi C, Zhu H. Hou W, et al. Front Immunol. 2022 Nov 22;13:1032314. doi: 10.3389/fimmu.2022.1032314. eCollection 2022. Front Immunol. 2022. PMID: 36483562 Free PMC article. Review.
Immunotherapy has revolutionized colon cancer treatment. Immune checkpoint inhibitors (ICIs) have shown clinical benefits for colon cancer patients, especially those with high microsatellite instability (MSI-H). ...Although MSI has been thought of as a …
Immunotherapy has revolutionized colon cancer treatment. Immune checkpoint inhibitors (ICIs) have shown clinical benefits for …
NCCN Guidelines Insights: Colon Cancer, Version 2.2018.
Benson AB, Venook AP, Al-Hawary MM, Cederquist L, Chen YJ, Ciombor KK, Cohen S, Cooper HS, Deming D, Engstrom PF, Garrido-Laguna I, Grem JL, Grothey A, Hochster HS, Hoffe S, Hunt S, Kamel A, Kirilcuk N, Krishnamurthi S, Messersmith WA, Meyerhardt J, Miller ED, Mulcahy MF, Murphy JD, Nurkin S, Saltz L, Sharma S, Shibata D, Skibber JM, Sofocleous CT, Stoffel EM, Stotsky-Himelfarb E, Willett CG, Wuthrick E, Gregory KM, Freedman-Cass DA. Benson AB, et al. J Natl Compr Canc Netw. 2018 Apr;16(4):359-369. doi: 10.6004/jnccn.2018.0021. J Natl Compr Canc Netw. 2018. PMID: 29632055 Free PMC article.
The NCCN Guidelines for Colon Cancer provide recommendations regarding diagnosis, pathologic staging, surgical management, perioperative treatment, surveillance, management of recurrent and metastatic disease, and survivorship. These NCCN Guidelines Insights summari …
The NCCN Guidelines for Colon Cancer provide recommendations regarding diagnosis, pathologic staging, surgical management, per …
Chemokines in colon cancer progression.
Jia SN, Han YB, Yang R, Yang ZC. Jia SN, et al. Semin Cancer Biol. 2022 Nov;86(Pt 3):400-407. doi: 10.1016/j.semcancer.2022.02.007. Epub 2022 Feb 7. Semin Cancer Biol. 2022. PMID: 35183412 Review.
Colon cancer is a major human cancer accounting for about a tenth of all cancer cases thus making it among the top three cancers in terms of incidence as well as mortality. ...Chemokines, the chemo-attractants for various immune cells, have increasingly been reporte
Colon cancer is a major human cancer accounting for about a tenth of all cancer cases thus making it among the top three cance
Colon cancer diagnosis and staging classification based on machine learning and bioinformatics analysis.
Su Y, Tian X, Gao R, Guo W, Chen C, Chen C, Jia D, Li H, Lv X. Su Y, et al. Comput Biol Med. 2022 Jun;145:105409. doi: 10.1016/j.compbiomed.2022.105409. Epub 2022 Mar 19. Comput Biol Med. 2022. PMID: 35339846
Advanced metastasis of colon cancer makes it more difficult to treat colon cancer. Finding the markers of colon cancer (Colon Cancer) can diagnose the stage of cancer in time and improve the prognosis with timely treatment. …
Advanced metastasis of colon cancer makes it more difficult to treat colon cancer. Finding the markers of col
Proteomic Analysis of Primary Colon Cancer and Synchronous Solitary Liver Metastasis.
Kim EK, Song MJ, Jung Y, Lee WS, Jang HH. Kim EK, et al. Cancer Genomics Proteomics. 2019 Nov-Dec;16(6):583-592. doi: 10.21873/cgp.20161. Cancer Genomics Proteomics. 2019. PMID: 31659112 Free PMC article. Clinical Trial.
BACKGROUND/AIM: Colon cancer is prone to distant metastases to other sites and the risk of recurrence is relatively high. Therefore, the identification of liver metastasis-related factors is important for the diagnosis or treatment of colon cancer. The …
BACKGROUND/AIM: Colon cancer is prone to distant metastases to other sites and the risk of recurrence is relatively high. Ther …
Development and validation of a five-immune gene prognostic risk model in colon cancer.
Chen H, Luo J, Guo J. Chen H, et al. BMC Cancer. 2020 May 6;20(1):395. doi: 10.1186/s12885-020-06799-0. BMC Cancer. 2020. PMID: 32375704 Free PMC article.
Currently, immunotherapy is a rapidly developing therapeutic modality of colon cancer. This study aimed to construct a prognostic risk model based on immune genes for the early diagnosis and accurate prognostic prediction of colon cancer. ...Besides, a …
Currently, immunotherapy is a rapidly developing therapeutic modality of colon cancer. This study aimed to construct a prognos …
miR-378 suppresses the proliferation, migration and invasion of colon cancer cells by inhibiting SDAD1.
Zeng M, Zhu L, Li L, Kang C. Zeng M, et al. Cell Mol Biol Lett. 2017 Jul 17;22:12. doi: 10.1186/s11658-017-0041-5. eCollection 2017. Cell Mol Biol Lett. 2017. PMID: 28725241 Free PMC article.
Our study focuses on the role of miR-378 in colon cancer cells. METHODS: Human colon cancer tissues and adjacent non-tumor tissues were collected from patients diagnosed in pathological examinations. ...CONCLUSION: miR-378 inhibits the proliferation, m …
Our study focuses on the role of miR-378 in colon cancer cells. METHODS: Human colon cancer tissues and adjacent …
The Economics of Colon Cancer.
Orangio GR. Orangio GR. Surg Oncol Clin N Am. 2018 Apr;27(2):327-347. doi: 10.1016/j.soc.2017.11.007. Epub 2017 Dec 13. Surg Oncol Clin N Am. 2018. PMID: 29496093 Review.
Costs vary by region, physician behavior, and patient preferences. When analyzing the economic burden of survivors of colon cancer, we cannot forget the societal burden. Post-acute care and readmissions are major economic burdens. People with colon cancer
Costs vary by region, physician behavior, and patient preferences. When analyzing the economic burden of survivors of colon cancer
11,707 results
You have reached the last available page of results. Please see the User Guide for more information.